Effect of anti-fibrinolytic therapy on experimental melanoma metastasis

Clinical and Experimental Metastasis

Volumn 26, Issue 2, 2009, Pages 121-131

  Kirstein, Jennifer M ^a,b   Graham, Kevin C ^a,b   MacKenzie, Lisa T ^b   Johnston, Danielle E ^b   Martin, Leslie J ^b   Tuck, Alan B ^a,b   MacDonald, Ian C ^b   Chambers, Ann F ^a,b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Anti fibrinolytic; Aprotinin; Coagulation; EACA; Metastasis

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; HEPARIN; PLASMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CELL GROWTH; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FIBRINOLYSIS; HISTOLOGY; LUNG METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; TUMOR CELL;

6-AMINOCAPROIC ACID; ANIMALS; APROTININ; CELL LINE, TUMOR; FEMALE; HEMOSTATICS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICROVESSELS;

EID: 60549105550     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-008-9221-z     Document Type: Article

References (57)

1. Henry DA, Carless PA, Moxey AJ et al (2007) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Syste Rev (Online: Update Software), (4), CD001886
2. D Royston BP Bidstrup KM Taylor 1987 Effect of aprotinin on need for blood transfusion after repeat open-heart surgery Lancet 2 8571 1289 1291 10.1016/S0140-6736(87)91190-1
3. M Levi ME Cromheecke E de Jonge 1999 Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 9194 1940 1947 10.1016/S0140-6736(99)01264-7
4. RC Landis G Asimakopoulos M Poullis 2001 The antithrombotic and antiinflammatory mechanisms of action of aprotinin The Annals of Thoracic Surgery 72 6 2169 2175 10.1016/S0003-4975(01)02821-1
5. TA Alston 2004 Aprotinin Int Anesthesiol Clin 42 4 81 91 10.1097/00004311-200404240-00009
6. DT Mangano Y Miao A Vuylsteke 2007 Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery J Am Med Assoc 297 5 471 479 10.1001/jama.297.5.471
7. DA Fergusson PC Hebert CD Mazer 2008 A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 22 2319 2331
8. WJ Brockway FJ Castellino 1971 The mechanism of the inhibition of plasmin activity by ε-aminocaproic acid J Biol Chem 246 14 4641 4647
9. D Amar FM Grant H Zhang 2003 Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery Anesthesiology 98 2 337 342 10.1097/00000542-200302000-00011
10. C Lentschener D Benhamou FJ Mercier 1997 Aprotinin reduces blood loss in patients undergoing elective liver resection Anesth Analg 84 4 875 881 10.1097/00000539-199704000-00032
11. AF Chambers LM Matrisian 1997 Changing views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst 89 17 1260 1270 10.1093/jnci/89.17.1260
12. Putnam JB, Royston D, Chambers AF et al (2003) Evaluating the role of serine protease inhibition in the management of tumor micrometastases. Oncology (Williston Park, N.Y.), 17(10, Suppl 10), 9-30 (quiz 1-2)
13. Collen D (2001) Ham-wasserman lecture: role of the plasminogen system in fibrin-homeostasis and tissue remodeling. Hematology 1-9. doi: 10.1182/asheducation-2001.1.1
14. P Nyberg M Ylipalosaari T Sorsa 2006 Trypsins and their role in carcinoma growth Exp Cell Res 312 8 1219 1228 10.1016/j.yexcr.2005.12.024
15. JD Crissman JS Hatfield DG Menter 1988 Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix Cancer Res 48 14 4065 4072
16. JH Im W Fu H Wang 2004 Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation Cancer Res 64 23 8613 8619 10.1158/0008-5472.CAN-04-2078
17. JS Palumbo KE Talmage JV Massari 2005 Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 1 178 185 10.1182/blood-2004-06-2272
18. JS Palumbo KW Kombrinck AF Drew 2000 Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells Blood 96 10 3302 3309
19. CA Staton NJ Brown CE Lewis 2003 The role of fibrinogen and related fragments in tumour angiogenesis and metastasis Expert Opin Biol Ther 3 7 1105 1120 10.1517/14712598.3.7.1105
20. GF Nash LF Turner MF Scully 2002 Platelets and cancer Lancet Oncol 3 7 425 430 10.1016/S1470-2045(02)00789-1
21. J Yu C Ustach HR Kim 2003 Platelet-derived growth factor signaling and human cancer J Biochem Mol Biol 36 1 49 59
22. P Mehta 1984 Potential role of platelets in the pathogenesis of tumor metastasis Blood 63 1 55 63
23. A Reijerkerk EE Voest MF Gebbink 2000 No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer Eur J Cancer 36 13 Spec No 1695 1705
24. GJ Caine GY Lip AD Blann 2004 Platelet-derived vegf, flt-1, angiopoietin-1 and p-selectin in breast and prostate cancer: Further evidence for a role of platelets in tumour angiogenesis Ann Med 36 4 273 277 10.1080/07853890410026098
25. EK Rofstad EF Halsor 2000 Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts Cancer Res 60 17 4932 4938
26. LW Bruggemann HH Versteeg TM Niers 2008 Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders J Cell Mol Med 10.1111/j.1582-4934.2008.00316.x
27. GA Turner L Weiss 1981 Analysis of aprotinin-induced enhancement of metastasis of lewis lung tumors in mice Cancer Res 41 7 2576 2580
28. B Boeryd B Hagmar G Johnsson 1974 Effects of eaca, amcha and guanethidine on metastases induced by intravenously injected tumour cells Pathol Eur 9 2 119 123
29. S Uetsuji M Yamamura S Takai 1992 Effect of aprotinin on metastasis of lewis lung tumor in mice Surg Today 22 5 439 442 10.1007/BF00308795
30. T Giraldi C Nisi G Sava 1977 Lysosomal enzyme inhibitors and antimetastatic activity in the mouse Eur J Cancer 13 11 1321 1323
31. R Stein-Werblowsky 1980 On the prevention of haematogenous tumour metastasis to liver and lung Experientia 36 1 108 109 10.1007/BF02004004
32. RP Hill AF Chambers V Ling 1984 Dynamic heterogeneity: rapid generation of metastatic variants in mouse b16 melanoma cells Science 224 4652 998 1001 10.1126/science.6719130
33. DR Goring J Rossant S Clapoff 1987 In situ detection of beta-galactosidase in lenses of transgenic mice with a gamma-crystallin/lacz gene Science 235 4787 456 458 10.1126/science.3099390
34. N Esumi D Fan IJ Fidler 1991 Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor Cancer Res 51 17 4549 4556
35. Rasband WS Imagej. National Institutes of Health 1997-2006, Bethesda. http://rsb.info.nih.gov/ij/
36. MD Cameron EE Schmidt N Kerkvliet 2000 Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Res 60 9 2541 2546
37. C Khanna K Hunter 2005 Modeling metastasis in vivo Carcinogenesis 26 3 513 523 10.1093/carcin/bgh261
38. KJ Luzzi IC MacDonald EE Schmidt 1998 Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases Am J Pathol 153 3 865 873
39. DC Brown AD Purushotham GD Birnie 1995 Detection of intraoperative tumor cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction Surgery 117 1 95 101 10.1016/S0039-6060(05)80235-1
40. JD Crissman J Hatfield M Schaldenbrand 1985 Arrest and extravasation of b16 amelanotic melanoma in murine lungs. A light and electron microscopic study Lab Invest 53 4 470 478
41. E Camerer AA Qazi DN Duong 2004 Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 104 2 397 401 10.1182/blood-2004-02-0434
42. SA Mousa R Linhardt JL Francis 2006 Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin Thromb Haemost 96 6 816 821
43. B Nieswandt M Hafner B Echtenacher 1999 Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 6 1295 1300
44. B Bereczky R Gilly E Raso 2005 Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest Clin Exp Metastasis 22 1 69 76 10.1007/s10585-005-3859-6
45. JS Palumbo JM Potter LS Kaplan 2002 Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice Cancer Res 62 23 6966 6972
46. AA Vaporciyan JB Putnam Jr WR Smythe 2004 The potential role of aprotinin in the perioperative management of malignant tumors J Am Coll Surg 198 2 266 278 10.1016/j.jamcollsurg.2003.09.022
47. R Stein-Werblowsky 1980 On the prevention of haematogenous tumor metastases rats. The role of the proteinase inhibitor "Trasylol" J Cancer Res Clin Oncol 97 2 129 135 10.1007/BF00409898
48. SM Smorenburg CJ Van Noorden 2001 The complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol Rev 53 1 93 105
49. V Bobek J Kovarik 2004 Antitumor and antimetastatic effect of warfarin and heparins Biomed pharmacother 58 4 213 219
50. TM Niers CP Klerk M DiNisio 2007 Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit Rev Oncol Hematol 61 3 195 207 10.1016/j.critrevonc.2006.07.007
51. CP Klerk SM Smorenburg HM Otten 2005 The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 10 2130 2135 10.1200/JCO.2005.03.134
52. AK Kakkar MN Levine Z Kadziola 2004 Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (famous) J Clin Oncol 22 10 1944 1948 10.1200/JCO.2004.10.002
53. M De Cicco 2004 The prothrombotic state in cancer: pathogenic mechanisms Crit Rev Oncol Hematol 50 3 187 196 10.1016/j.critrevonc.2003.10.003
54. JS Palumbo KE Talmage JV Massari 2007 Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and -independent mechanisms Blood 110 1 133 141 10.1182/blood-2007-01-065995
55. JP Biggerstaff B Weidow J Vidosh 2006 Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis Thromb J 4 12 10.1186/1477-9560-4-12
56. KV Honn DG Tang IM Grossi 1994 Enhanced endothelial cell retraction mediated by 12(s)-hete: A proposed mechanism for the role of platelets in tumor cell metastasis Exp Cell Res 210 1 1 9 10.1006/excr.1994.1001
57. KV Honn D Tang 1992 Hemostasis and malignancy: an overview Cancer Metastasis Rev 11 3-4 223 226 10.1007/BF01307178